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Introduction
　We hypothesized that cells derived from dental pulp 
would possess the characteristics of mesenchymal stem 
cells（MSCs）and be able to undergo in vitro differenti-
ation into any type of somatic cells, including osteo-
cytes, adipocytes and myocytes.  We previously showed 
that mineralization of rat dental pulp stem cells in-
creased at around 6 weeks after in vitro osteogenic in-
duction, as determined by von Kossa staining, although 
it was detected at low levels for 3 weeks after induc-
tion1.  Some previous studies have provided evidence for 
the existence of adult human MSCs in bone marrow, 
and MSCs are known to have the potential to differenti-
ate into cells with mesenchymal, mesodermal, neuroec-
todermal or endodermal characteristics2-5.  Moreover, 
several markers for stem cells have been identiﬁ ed, 
such as STRO-1, SSEA-1, Nanog and Oct-3/4.  STRO-1 
is expressed in stromal cell precursors in human bone 
marrow and this STRO-1-expressing subset of bone 
marrow cells is capable of differentiating into multiple 
mesenchymal lineages6，7.  Expression of SSEA-1 is 
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Abstract : The in vitro differentiation potential of rat dental pulp-derived cells into an osteoblastic lineage 
was examined.  Induction was carried out under in vitro osteogenesis-inducing conditions used for mesenchy-
mal stem cells from human bone marrow.  We previously reported that the level of mineralization was high at 
6 weeks after induction, as determined by von Kossa staining.  In the present study, we quantitatively mea-
sured the alkaline phosphatase（ALP）activity after induction.  The ratios of ALP-positive cells to total cells 
were 44.4± 1.0, 46.9± 0.9, 40.5± 0.5 and 21.0± 1.8% at 1, 2, 3 and 6 weeks after induction, respectively.  
The level of ALP activity was signiﬁ cantly decreased at 6 weeks after induction（p＜ 0.05）.  The stem cell 
markers STRO-1, SSEA-1, Nanog and Oct-3/4 were expressed in a subset of the cells, suggesting that stem 
cells were present.  To elucidate gene regulation in the osteoblastic lineage of the cells, quantitative gene ex-
pression analyses were carried out using real-time RT-PCR.  Col1a2（collagen type I）and Bglap（osteocal-
cin）were up-regulated by about 1.7-fold and 1.3-fold, respectively, at 6 weeks after induction compared with 
their corresponding levels at 1 week.  These results indicate that the cells differentiated into an osteoblastic 
lineage in parallel with decreasing ALP activity during induction.  Moreover, the expressions of Col1a2 and 
Bglap were inversely correlated with Alpl（ALP）expression after induction, which was correlated with 
Bmp2（bone morphogenetic protein 2）expression.  Taken together, the ﬁ ndings indicate that these molecules 
contribute to the differentiation of rat dental pulp-derived cells into an osteoblastic lineage.
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down-regulated following differentiation of murine ES 
cells8.  Nanog is required for maintenance of ES cell 
self-renewal independently of LIF/Stat3, and Nanog-de-
ﬁ cient ES cells lose their pluripotency9.  Oct-3/4 is a 
POU family transcription factor that is speciﬁ cally ex-
pressed in ES cells, embryos, epiblasts and germ cells10. 
Inactivation of Oct-3/4 in ES cells results in loss of their 
pluripotency11.  Differentiation of osteoprogenitor cells 
or bone marrow-derived MSCs into osteoblasts can be 
induced in vitro by treating the cells with ascorbic acid, 
β-glycerophosphate and dexamethasone12-14. In the 
present study, we examined the in vitro osteogenic dif-
ferentiation of rat dental pulp-derived cells by applying 
the in vitro conditions used for human bone marrow 
cells2.  Although a previous study involving ex vivo 
transplantation of human dental pulp stem cells derived 
from an exfoliated deciduous tooth into immunocompro-
mised mice showed that these cells could induce bone 
formation15, the gene regulation involved in the osteo-
genic differentiation of dental pulp stem cells remains 
unclear.  MSCs-derived bone marrow cells are known to 
undergo sequential growth, differentiation and matura-
tion after osteogenic induction.  Following an increase 
in cell number, synthesis of collagen type I and alkaline 
phosphatase（ALP）activity are detected, after which 
secretion of osteocalcin and mineralization of the extra-
cellular matrix are enhanced16.  To elucidate the gene 
regulation in our osteoblastic lineage of rat dental pulp-
derived cells, quantitative gene expression analyses 
were performed following in vitro osteogenic induction.
Materials and Methods
1. Cell culture
　Five-week-old male Wistar rats were used in this 
study（SHIMIZU Laboratory Supply, Kyoto, Japan）. 
The procedures for the primary culture were described 
previously1.  Brieﬂ y, the pulp tissue was gently separat-
ed from the posterior of the mandible using reamers
（25mm #10 ; Morita Corporation, Osaka, Japan）.  The 
tissue was then minced in PBS（－）and incubated in 
PBS（－）containing 3 mg/mL collagenase type I（Invit-
rogen, Carlsbad, CA, USA）and 4 mg/mL dispase（Invit-
rogen）for 30 minutes at 37℃.  Next, the cells were in-
oculated onto dishes coated with collagen type I or Lab-
Tek II chamber slides（Nalge Nunc International K.K., 
Rochester, NY, USA）and cultured in basic medium 
consisting of alpha modiﬁ ed minimum essential medi-
um Eagle（α-MEM; Sigma-Aldrich, St. Louis, MO, 
USA）supplemented with 20% fetal calf serum（FCS; 
Invitrogen）.  All animal experiments were carried out 
in accordance with the guidelines of Osaka Dental Uni-
versity for the care and use of laboratory animals.
2. Immunoﬂ uorescence analysis
　After extraction, the dental pulp-derived cells were 
cultured on Lab-Tek II chamber slides（Nalge Nunc In-
ternational K.K.）in basic medium for 2 days, and the 
expressions of stem cell markers were analyzed using 
an immunoﬂ uorescence technique.  The primary anti-
bodies used in this study are listed in Table 1.  After ﬁ x-
ation with 4%（w/v）paraformaldehyde solution, the 
cells were treated with 0.1 M phosphate buffer contain-
ing 0.1% Triton X-100, washed with 10 mM glycine in 
PBS（－）and incubated in 3%（w/v）BSA in PBS（－）
for 30 minutes at room temperature to block nonspeciﬁ c 
reactions.  After washing with 10 mM glycine in PBS
（－）, the cells were incubated with an appropriately di-
luted primary antibody for 1 hour at room temperature, 
washed with 0.1% BSA in PBS（－）and incubated for 1 
hour at room temperature with a ﬂ uorescently labeled 
secondary antibody, which had been adsorbed against 
the IgG of other species such as cows, goats, rats and 
humans. Speciﬁ cally, the secondary antibodies were 1 
μg/mL Alexa 546-conjugated goat anti-mouse IgG（H
＋ L）high cross-adsorbed（Molecular Probes Inc., Eu-
gene, OR, USA）and 1 μg/mL Alexa 546-conjugated 
goat anti-rabbit IgG（H＋ L）high cross-adsorbed（Mo-
Table 1　Antibodies against stem cell markers used in the immunoﬂ uorescence analysis
Antigen Concentration Company Product number
STRO-1
SSEA-1
Nanog
Oct-3/4
10 μg/mL
10 μg/mL
0.3 μg/mL
1.0 μg/mL
R&D SYSTEMS
CHEMICON INTERNATIONAL
ReproCELL
CHEMICON INTERNATIONAL
MAB1038
MAB4301
RCAB0001P
AB3209
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lecular Probes Inc.）.  The samples were then washed 
with 0.1% BSA in PBS（－）, counterstained with a ﬂ uo-
rochrome（SYTOX Green; Molecular Probes Inc.）and 
mounted in Permafluor（Immunotech, Marseille, 
France）.  The immunoﬂ uorescence signals were detect-
ed using a confocal laser scanning microscopy system
（FLUOVIEW FV300; Olympus Corporation, Tokyo, Ja-
pan）.
3. In vitro osteogenic induction assay 
　Cells were cultured for 7 days in the basic medium 
supplemented with 100 μM L-ascorbic acid 2-phosphate
（ASC-2P; Wako Pure Chemicals, Osaka, Japan）, 1×
10－5 M β-mercaptoethanol and 2 mM L-glutamine at 
37℃ in a 5% humidiﬁ ed CO2 atmosphere.  For osteogen-
ic induction, the cells were maintained in α-MEM sup-
plemented with 10% FCS, 2 mM L-glutamine, 1× 10－8 
M dexamethasone sodium phosphate（Wako Pure 
Chemicals）, 100 μM ASC-2P and 1.8 mM KH2PO4
（Wako Pure Chemicals）to give a ﬁ nal phosphate con-
centration of 2.9 mM, and 20 mM HEPES（Sigma-Al-
drich）.  The medium was changed twice a week for 
varying periods of up to 6 weeks.
4. ALP activity
　Cells cultured on chamber slides were ﬁ xed in cold 
95% ethanol, and their ALP activity was detected ac-
cording to the instructions supplied by SRL Inc.（Tokyo, 
Japan）.  Brieﬂ y, the cells were rehydrated through a 
graded alcohol series, stained with Fast Blue RR Salt
（Sigma-Aldrich）, Naphthol AS-MX phosphate（Wako 
Pure Chemicals）and N, N-dimethylformamide（Wako 
Pure Chemicals）in buffered 2-amino-2-methyl-1, 
3-propandiol（2 M, pH 8.6 ; Wako Pure Chemicals）, and 
counterstained with Kernechtrot solution（Muto Pure 
Chemicals, Tokyo, Japan）.  After mounting with glycer-
in and gelatin（Wako Pure Chemicals）, positive signals 
were counted under a microscope equipped with a CCD 
camera（BX33-S ; Olympus Corporation）.  The numbers 
of positive signals were averaged for 4 independent 
samples at 1, 2 and 3 weeks, and 6 independent samples 
at 6 weeks. Differences in values were evaluated statis-
tically by Mann-Whitney U tests using SPSS software 
version 12.0J（SPSS Inc., Chicago, IL, USA）.
5. Quantitative real-time RT-PCR assay
　Total RNA was isolated using Trizol（Invitrogen）in 
accordance with the manufacturer’s instructions.  After 
treatment with DNase to remove possible contamina-
tion by genomic DNA, samples were subjected to real-
time RT-PCR using a Real-Time RT-PCR Core Kit（Ta-
kara Bio Inc., Otsu, Japan）to examine the expression 
levels of collagen type I alpha 2（Col1a2）, osteocalcin
（Bglap）, ALP（Alpl）and bone morphogenetic protein 2
（Bmp2）.  The rat-speciﬁ c PCR primers used are listed 
in Table 2.  To avoid ampliﬁ cation of the genome, the 
primer sets were designed to include the exon junction. 
PCR ampliﬁ cation was performed using an initial incu-
bation of 10 seconds at 95℃, followed by 45 cycles of 
95℃ for 5 seconds and 60℃ for 20 seconds.  Rat glycer-
aldehyde-3-phosphate dehydrogenase（Gapdh）was 
used as an internal control to correct the quantitative 
analysis.
Results
1. Expressions of stem cell markers in dental 
pulp-derived cells
　STRO-1, SSEA-1, Nanog and Oct-3/4 were detected in 
a subset of the rat dental pulp-derived cells（Fig. 1）. 
The expressions of these markers were localized in the 
nuclei of the positive cells.
2. Changes in ALP activity after induction
　A time-course analysis of ALP activity during the os-
teogenic differentiation process was carried out, in 
Table 2　Marker genes used in the quantitative real-time RT-PCR assay
Gene Primer nucleotide sequence Accession number
Gapdh
Col1a2
Bglap
Alpl
Bmp2
Forward 5’-GACAACTTTGGCATCGTGGA-3’ Reverse 5’-ATGCAGGGATGATGTTCTGG-3’
Forward 5’-TTCCCGGTGAATTCGGTCTC-3’ Reverse 5’-ACCTCGGATTCCAATAGGACCAG-3’
Forward 5’-AGACTCCGGCGCTACCTCAA-3’ Reverse 5’-CGTCCTGGAAGCCAATGTG-3’
Forward 5’-CGCCTATCAGCTAATGCACAACA-3’ Reverse 5’-ATGAGGTCCAGGCCATCCAG-3’
Forward 5’-AACACCGTGCTCAGCTTCCA-3’ Reverse 5’-TTCCCACTCATTTCTGAAAGTTCC-3’
NM_017008
NM_053356
NM_013414
NM_013059
NM_0017178
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which cells showing positive ALP activity at 1, 2, 3 and 
6 weeks after induction were stained blue（Fig. 2A）. 
The ratios of ALP-positive cells to total cells were 44.4
± 1.0%, 46.9± 0.9%, 40.5± 0.5% and 21.0± 1.8% at 
1, 2, 3 and 6 weeks after induction, respectively.  The 
levels of ALP activity were signiﬁ cantly decreased at 3 
and 6 weeks compared with 1 and 2 weeks after induc-
tion（p＜ 0.05）, whereas the levels of ALP activity did 
not differ signiﬁ cantly between 1 and 2 weeks（Fig. 
2B）.  These results show that ALP activity is up-regu-
lated at an early stage of osteogenic differentiation.
Fig. 1　Expressions of stem cell markers by rat dental pulp-derived cells. Left panels : 
positive staining for each marker ; right panels : counter-staining of the nuclei. 
a-b : STRO-1 ; c-d : SSEA-1 ; e-f : Nanog ; g-h : Oct-3/4. Scale bar : 200 μm. 
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3. Expression of genes related to differentiation 
into an osteoblastic lineage
　Col1a2 and Bglap were up-regulated by approximate-
ly 1.7-fold and 1.3-fold, respectively, at 6 weeks after in-
duction compared with their corresponding levels at 1 
week（Figs. 3A and B）.  On the other hand, Alpl and 
Bmp2 were down-regulated by approximately 0.6-fold 
and 0.3-fold, respectively, at 6 weeks compared with 
their corresponding levels at 1 week（Figs. 3C and D）. 
Moreover, the expressions of Col1a2 and Bglap were in-
versely correlated with Alpl expression after induction. 
Fig. 2　A: Time-course analysis of in vitro osteogenic dif-
ferentiation of rat dental pulp stem cells at 1
（a）, 2（b）, 3（c） and 6（d） weeks after induc-
tion. All panels show staining for ALP activity. 
Cells stained blue are positive for ALP activity. 
ALP activity is detected in characteristically 
osteoblastic lineage cells. Scale bar : 200 μm.
B: Quantitative measurement of ALP-positive 
cells. The numbers of ALP-positive cells were 
counted at 1, 2, 3 and 6 weeks after osteogenic 
induction. The values represent the mean ± 
standard error of 4（1, 2 and 3 weeks）or 6（6 
weeks）independent slides in each group. As-
terisks denote values that are statistically dif-
ferent from the values at 1 and 2 weeks. ＊p＜
0.05.
A
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Discussion
　Postnatal stem cells have been isolated from a variety 
of tissues including bone marrow, brain, skin, hair folli-
cles, skeletal muscle and dental pulp13，17-21.  Naturally 
occurring human exfoliated deciduous teeth are similar 
to the umbilical cord, since both contain stem cells15.  To 
evaluate the existence of stem cells in dental pulp-de-
rived cells, immunoﬂ uorescence analyses of the stem 
cell markers STRO-1, SSEA-1, Nanog and Oct-3/4, 
which are known to be expressed in MSCs and murine 
ES cells, were carried out.  All these markers were de-
tected in a subset of our dental pulp-derived cells, sug-
gesting that dental pulp contains a type of stem cells. 
Although these cells have the potential to differentiate 
into multiple lineages, conﬁ rmation of their pluripoten-
cy requires further evidence that the cells can differen-
tiate into other somatic cells such as osteocytes, adipo-
cytes, myocytes and neurocytes.
　Studies on ectopic osteogenesis, such as transplanta-
tion of human dental pulp-derived cells and hydroxyap-
atite into the hypodermis of immunocompromised mice, 
have been reported15，22.  We previously showed that 
mineralization of rat dental pulp-derived cells increased 
at 6 weeks using an in vitro system of osteogenic induc-
tion1, although the molecular mechanisms of this in 
vitro osteogenic differentiation remained unclear.  To 
elucidate the applicability of dental pulp stem cells as 
clinically relevant engineering materials, we examined 
the gene regulation involved in the differentiation of rat 
dental pulp-derived cells into an osteoblastic lineage.
　In rat and human MSCs2，22-24, osteogenesis is deﬁ ned 
by ALP activity, markers for osteogenic cells, osteocalcin 
and collagen type I mRNA expressions and mineraliza-
tion of the matrix.  In the present study, ALP activity 
decreased in the late stage of induction when mineral-
ization became remarkable, although it was up-regulat-
ed at an early stage（around 2 weeks）.  ALP activity 
has been reported to decrease in the late stage of bone 
differentiation of bone marrow stem cells.  The sequen-
tial changes in ALP activity seen in our rat dental pulp-
derived cells after induction are therefore considered to 
be similar to the ALP activity observed during osteogen-
esis of MSCs from human and rodent bone marrow. 
The increased expressions of Col1a2 and Bglap mRNAs 
at 6 weeks after induction were inversely correlated 
with the changes in ALP activity after induction, and 
this may be important during the differentiation of rat 
dental pulp-derived cells into an osteoblastic lineage. 
On the other hand, Bmp2 was also down-regulated by 
less than 30% at 6 weeks, along with a decrease in Alpl 
mRNA expression.  A previous study demonstrated that 
Bmp2, a member of the transforming growth factor-β 
superfamily, and the Runx2（AML3/Cbfa1）transcrip-
tion factor, a downstream Bmp2 effector, are regulatory 
signals required for osteoblastic differentiation25.  Re-
cently, Bmp2-induced expression of Alpl mRNA, an ear-
ly marker reﬂ ecting Runx2, was also reported to control 
osteoblastic differentiation.  Bmp2-mediated osteogene-
sis requires Runx2, and the initiation of Bmp2-induced, 
Runx2-dependent gene expression requires SWI/SNF 
chromatin remodeling complexes20.  Bone morphogenic 
proteins are important regulators of osteoblastic differ-
entiation.  In human21 and rodent28，29 in vitro systems, 
Fig. 3　Quantitative analysis of mRNA expressions by re-
al-time RT-PCR. The relative expression levels of 
Col1a2（A; 1.7-fold increase）, Bglap（B; 1.3-fold 
increase）, Alpl（C; 0.6-fold decrease）and Bmp2
（D; 0.3-fold decrease）are shown. The X-axis 
shows the time after osteogenic induction. Values 
were corrected using Gapdh as the standard.
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Bmp2 stimulates the differentiation of previously com-
mitted preosteoblastic cells30，31.  In rat dental pulp-de-
rived cells, the high level of Bmp2 expression at an ear-
ly stage of induction is thought to be a key for the 
recruitment of other markers associated with osteogen-
esis or the promotion of chromatin remodeling for tran-
scription32. 
　Pluripotent cells are an attractive and promising tool 
in the ﬁ eld of tissue regeneration and engineering.  We 
therefore believe that the present ﬁ ndings support the 
suggestion that the potential stem cells in dental pulp 
may be a potential osteogenetic source able to function 
as clinically relevant engineering materials.  In conclu-
sion, we believe these molecules contribute to the differ-
entiation of rat dental pulp-derived cells into an osteo-
blastic lineage as well as the differentiation of MSCs 
from bone marrow.
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